CVE-2026-19731: Path Traversal in TÜBİTAK BİLGEM's İmzager
TÜBİTAK BİLGEM Software Technologies Research Institute · İmzager
Fixed in 2.10.7 · Affected: TÜBİTAK BİLGEM Software Technologies Research Institute İmzager before 2.10.7 · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 2% of scored CVEs
DescriptionCVE.org
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager allows Path Traversal. This issue affects İmzager: from 2.10.5 before 2.10.7.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- TÜBİTAK BİLGEM Software Technologies Research Institute · İmzagerfrom 2.10.5 before 2.10.7
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Published
- November 2026
CoverageNo articles yet
No CyberSIXT article names CVE-2026-19731 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.